TURIN/AMSTERDAM (Reuters) - The CEO of Exor NV, the largest shareholder in Dutch healthcare equipment maker Philips NV, on Thursday said he continues to believe the company's problems are solvable.

MILAN, Feb 16 (Reuters) - Exor, the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics group to insurer Reale ...

Thinking about what to do with your Exor shares, or whether now might be the perfect moment to start a position? You are far from alone. This diversified holding company has been making waves and ...

Exor owns stakes in a group of public and private companies, notably a nearly 20% stake in Ferrari, the top luxury car maker in the world. Its shares look cheap.

Exor’s FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and ...

22,965,749 Ordinary Shares were validly tendered by Qualifying Shareholders in the Tender Offer and, following application of the scaling-down mechanism set out in the Offer Memorandum, 12,254,495 ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, and Exor N.V. (AEX: EXO), the Netherlands-based diversified holding company, announce they have ...

Exor is the Amsterdam-listed holding company of the Agnelli family, who own 55.2% of the economic interest, but control over 85% of the voting rights. Exor controlled 35.5% of Source Perrier, the ...

Ferrari shares were down 7% in early trading after closing on Wednesday at 483 euros, near their record high. Exor, the holding company of Italy's Agnelli family, raised about 3 billion euros ($3.14 ...

MILAN -- Italy's Exor said on Monday it had agreed to invest $200 million to buy an 8.87 percent stake in New York-based shared mobility company Via Transportation, in what would be the first step by ...

Sometimes the parts are worth more than the whole. That’s the case with Exor, whose massive discount has created a low-risk bet for value-seeking investors.